If you’ve ever felt a sudden, brief electric jolt somewhere in your head, gone in less than a second but strange enough to stop you mid-sentence, you are not imagining it, and you are not alone in searching for an explanation. Women describe it in strikingly similar terms: a zap, a shiver, a static shock behind the eyes, sometimes triggered by simply moving your eyes or turning your head.

This is one of those symptoms that shows up in perimenopause forums and comment sections, and almost nowhere in the medical literature about perimenopause itself. That gap is worth talking about honestly, because you deserve a real answer, not a reassuring guess dressed up as one.

Here is what the evidence actually shows, and where it runs out.

What brain zaps are, according to the research we have

The sensation you’re describing already has a name in medicine, just not one connected to hormones. “Brain zaps” are well documented as a feature of antidepressant discontinuation syndrome, the cluster of symptoms that can appear after stopping or reducing antidepressant medications known as serotonin reuptake inhibitors (SSRI) or serotonin norepinephrine reuptake inhibitors (SNRI). The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) is the professional reference book on mental health. It recognizes this syndrome and symptoms typically begin within two to four days of stopping those types of medications.

The leading explanation involves the serotonin system. When an SSRI or SNRI is discontinued or reduced, the brain experiences a kind of rebound, a temporary hyperexcitability or increased sensitivity in serotonergic neurons that had adjusted to the presence of the medication. Research has shown increased activity markers in these neurons and a surge in serotonin release immediately after discontinuation. Some researchers believe the picture is more layered than a simple rebound, involving a shifting balance between serotonin receptor sensitivity, transporter recovery, and enzyme activity as the brain recalibrates.

In short: brain zaps are real, they are studied, and they have a plausible neurological mechanism, just not one that has been formally connected to perimenopause on its own.

So why does it feel so connected to perimenopause?

Because the physiology is likely similar, even though the research hasn’t caught up.

Perimenopause is not simply a story of “declining estrogen.” Estrogen can rise and fall unpredictably, sometimes shifting significantly over relatively short periods of time.

Those fluctuations matter because estrogen interacts with several of the brain systems that help regulate mood, sensation, and nervous system activity. It influences serotonin, including how serotonin is produced, received, and recycled in the brain. This is the same neurotransmitter system implicated in the “brain zaps” some people experience with abrupt changes in serotonergic medications.

Estrogen also interacts with GABA, one of the brain’s primary calming systems. As estrogen and related neurosteroids fluctuate during perimenopause, GABA signaling can change too. The result is that the nervous system may feel more settled at some times and more reactive or excitable at others.

This is part of what makes perimenopause so confusing. The hormones are not simply going down. The hormonal environment is changing, sometimes unpredictably, and the brain is responding to those changes too.

This is one reason researchers increasingly recognize perimenopause as more than a reproductive transition. It is also a neurological one. Changing hormone patterns interact with the brain systems involved in temperature regulation, sleep and circadian rhythm, sensory processing, mood, and cognition.

This brings us back to brain zaps. Some of the same neurotransmitter systems affected by changing ovarian hormones are also implicated in the brain zaps associated with discontinuing certain serotonergic medications. That overlap offers a plausible biological explanation for why some women report similar sensations during perimenopause.

However, there is an important distinction between plausible and proven. Brain zaps during perimenopause have not been directly studied well enough to establish their mechanism or even confirm that hormonal fluctuations are the cause.

The connection makes physiological sense. It remains a hypothesis, not an established explanation.

What the research does not show

This is the part that matters most, and the part that is often missing from conversations about brain zaps and perimenopause.

Brain zaps are not currently recognized as an established, independent symptom of perimenopause. They do not appear as a distinct symptom in clinical guidelines or the larger studies that characterize the perimenopausal transition. Those studies consistently capture symptoms such as brain fog, headaches, anxiety, fatigue, and sleep disruption. Brain zaps have not emerged in the same way.

That absence is important, but it does not tell us that the sensation is not real or that women are not experiencing it. It tells us that this particular symptom, in this particular context, has not been adequately studied.

Those are very different conclusions.

Women’s lived experiences can raise questions before research has had the opportunity to answer them. Brain zaps may ultimately prove to have a relationship with hormonal fluctuations, or another explanation may emerge as they are studied more carefully.

For now, the most accurate answer is that women report them, there are biologically plausible reasons to investigate the connection, but the evidence has not yet established brain zaps as a symptom of perimenopause.

What to know if you’re experiencing brain zaps

Since the best-established association with brain zaps is medication discontinuation or dose changes, medication history is an important part of understanding the symptom. This is particularly relevant during perimenopause, when SSRIs and SNRIs may be prescribed for mood symptoms or vasomotor symptoms such as hot flashes.

If you’re discussing these sensations with your clinician, a few details may help provide context:

• Medication changes. Have you recently reduced a dose, switched medications, or missed a dose of an SSRI or SNRI? Some medications, particularly those with shorter half-lives such as venlafaxine, can produce discontinuation symptoms relatively quickly after a missed or reduced dose.
• Timing. When did the sensations begin? Did they appear around a medication change, or did they begin independently?
• Pattern. Do they seem to occur alongside other changes associated with perimenopause, such as changing cycles, night sweats, sleep disruption, or mood changes? Or do they occur without any obvious pattern?
• What the sensation is actually like. Brain zaps are typically described as very brief, shock-like or electrical sensations in the head. More prolonged symptoms, or symptoms accompanied by confusion, loss of awareness, unusual repetitive movements, or other new neurological changes, are not something to simply assume is a brain zap or attribute to perimenopause. They warrant medical evaluation.

If medication effects and other potential causes are ruled out, you may be left with an answer that feels less satisfying: we simply do not know enough yet about brain zaps reported during perimenopause.

Your clinician may not have a definitive explanation either. That uncertainty is worth naming rather than filling the gap with a mechanism that has not been established.

Sometimes good medical care begins not with pretending we have an answer, but with being clear about what we know, what we don’t, and what deserves further attention.

The bottom line

Brain zaps are a well-described feature of SSRI and SNRI discontinuation, so recent medication changes, dose reductions, or missed doses are an important part of the picture to consider.

When similar sensations are reported during perimenopause without a medication explanation, the science becomes much less certain. There are physiologically plausible reasons to wonder whether changing ovarian hormones and their effects on the brain could play a role. However, that connection has not been directly established.

Plausible is not the same as proven. Unstudied is not the same as unreal.

Right now, the most accurate answer is that the research has not adequately answered the question.

You do not need a published study for a symptom to deserve thoughtful attention. What matters is approaching it with curiosity rather than assumption: considering explanations we already understand, recognizing when something needs further evaluation, and being willing to say “we don’t know yet” when the evidence ends.

That uncertainty is not a failure of understanding. It is where the next good question begins.

Where to go from here

Perimenopause produces a long list of symptoms that rarely get named clearly, let alone explained. Clarity’s Perimenopause Learning Path walks through the neurological, hormonal, and emotional shifts of this transition in depth, so you have language for what you’re experiencing before you’re sitting in an appointment trying to describe it in real time.

Use the free MyCare Conversation Guide to track symptoms like this one and bring a clear, specific account to your next appointment, rather than a hard-to-explain sensation you’re worried will be brushed off.

This article is for educational purposes only and is not a substitute for individualized medical care. Please consult your clinician about your specific symptoms and health history.

References

1. Renoir T. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and possible mechanisms. Frontiers in Pharmacology. 2013;4:45. Read the study

2. Barkho A, Elhusein B, Gajebasia N. A rare case of antidepressant discontinuation syndrome triggered by domperidone: clinical insights and literature review. 2025. Read the case report

3. Papp A, Onton JA. Brain zaps: an underappreciated symptom of antidepressant discontinuation. Primary Care Companion for CNS Disorders. 2018;20(6):18m02311. Read the study

4. Rebound activation of 5-HT neurons following SSRI discontinuation. Neuropsychopharmacology. 2024;49:1580–1589. Read the study

5. Delgado JC, et al. Clustering of more than 145,000 symptom logs reveals distinct pre-, peri-, and menopausal phenotypes. Scientific Reports. 2025. Read the study

6. Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nature Reviews Endocrinology. 2015;11(7):393–405. Read the review

Evidence note: Research directly linking brain zaps with perimenopause is limited. Most published evidence concerns antidepressant discontinuation, while the perimenopause research provides broader neurological context rather than proof of a direct connection.

Medically reviewed by April Lind, MD · Last reviewed [August 2026]